Mercado global de tratamento do cancro das amígdalas – Tendências do setor e previsão para 2028

Análise de mercado e insights: Mercado global de tratamento do cancro das amígdalas

Espera-se que o mercado de tratamento do cancro das amígdalas ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer a um CAGR de 5,00% no período de previsão de investigação acima referido. Aumento da incidência das amígdalas em todo o mundo e introdução de novos tratamentos e terapias.

A crescente procura por terapias e tratamentos eficazes nos mercados emergentes e a crescente consciencialização entre os doentes também impulsionam o crescimento do mercado. Além disso, os vigorosos esforços de investigação e desenvolvimento e o aumento do apoio e financiamento governamental para o tratamento do cancro funcionam como uma oportunidade para o crescimento do mercado. Mas, os efeitos adversos relacionados com os medicamentos, a falta de profissionais qualificados e o longo procedimento de aprovação de medicamentos e terapias podem dificultar o mercado global de tratamento do cancro das amígdalas.

A garganta tem três tipos de amígdalas: as amígdalas palatinas nos lados da garganta, as amígdalas faríngeas (adenóides) na parte posterior da garganta e as amígdalas que se encontram na base da língua, que são as amígdalas linguais. O cancro das amígdalas geralmente afeta as amígdalas palatinas. Foi relatado que o cancro das amígdalas afeta principalmente os homens em comparação com o das mulheres.

Existem várias causas associadas ao cancro das amígdalas, que incluem a imunidade fraca e o tabagismo, entre outras. Entre os diferentes tipos de causas, o tabagismo é o mais frequente. Vários sintomas relatados em doentes com cancro das amígdalas são sangue na saliva, dor na boca, dificuldade em engolir, dor de ouvidos forte, mau hálito, entre outros.

O cancro das amígdalas pode ser diagnosticado por exames de imagem e de sangue, que determinam a localização e a malignidade dos estádios do cancro. Vários medicamentos e terapias foram aprovados para o tratamento do cancro das amígdalas, que envolve quimioterapia, radioterapia e cirurgia. A prevalência do cancro das amígdalas está a aumentar em todo o mundo devido ao aumento do número de fumadores e ao aumento dos casos de HPV, o que deverá impulsionar o crescimento do mercado.

This tonsil cancer treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Tonsil Cancer Treatment Market Scope and Market Size

Tonsil cancer treatment market is segmented on the basis of type, route of administration, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of type, the tonsil cancer treatment market is segmented surgery, radiation therapy and chemotherapy. Surgery segment is further sub-segmented into transoral robotic surgery (TORS), transoral laser microsurgery (TLM) and others. Chemotherapy is sub-segmented into cisplatin, carboplatin, 5-fluorouracil (5-FU), paclitaxel (Taxol), docetaxel (Taxotere), hydroxyurea and other drugs. Other drugs segment is further sub-segmented into methotrexate, bleomycin, and capecitabine.

• On the basis of route of administration, the tonsil cancer treatment market is segmented into parenteral, topical, oral and others.
• On the basis of end-users, the tonsil cancer treatment market is segmented into hospitals, clinics, home healthcare and ambulatory surgical centers.
• On the basis of distribution channel, the tonsil cancer treatment market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.

Tonsil Cancer Treatment Market Country Level Analysis

Tonsil cancer treatment market is analysed and market size information is provided by country, type, route of administration, end-users and distribution channel as referenced above.

The countries covered in the tonsil cancer treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America accounts the largest market share due to the presence of high healthcare expenditure and increasing research and development for cancer treatment. Europe accounts the second largest market share due to increasing number of smokers. Asia-Pacific is expected to account for the largest market share over coming years for the tonsil cancer treatment market due to high patients’ base and growing investment by market players towards emerging economies.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Tonsil cancer treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Tonsil Cancer Treatment Market Share Analysis

Tonsil cancer treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to tonsil cancer treatment market.

The major players covered in the tonsil cancer treatment market are Bristol-Myers Squibb Company, Pfizer Inc., Teva Pharmaceuticals USA, Inc., MANUS AKTTEVA BIOPHARMA LLP, Accord-UK Ltd., AMIGOZ Lifesciences, R&D Systems, Inc., Mylan N.V., Isofol Medical AB, Sanofi-aventis U.S LLC, Sun Pharmaceutical Industries Ltd., Actiza Pharmaceutical Private Limited, Biozenta Lifescience Pvt. Ltd., Florencia Healthcare, Hetero Healthcare Limited, sterling, Angel Biogenics Private Limited, zuviuslifesciences, Fresenius Kabi Canada, Tecoland Corporation, Hikma Pharmaceuticals PLC and Azurity Pharmaceuticals, Inc., among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-58966